Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone
Evaluation of Immediate Implant Placement Using the Socket Shield Technique in Maxillary Esthetic Zone (Clinical and Radiographic Study)
1 other identifier
interventional
8
1 country
1
Brief Summary
Immediate implant placement in the esthetic zone is an approach that helps preserve soft and hard tissue architecture. However, post extraction bone resorption is still a significant challenge. The socket shield technique (SST) has emerged as a promising way for preserving the buccal plate, potentially improving implant stability and reducing radiographic bone loss. The aim of the present study is to evaluate the clinical and radiographic outcomes of the socket shield technique in the maxillary esthetic zone by assessing implant stability, radiographic bone loss as well as esthetic outcome over a specified follow-up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2025
CompletedFirst Posted
Study publicly available on registry
July 24, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
July 24, 2025
July 1, 2025
9 months
July 15, 2025
July 23, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in pain scores
Pain will be evaluated, using visual analogue scale (VAS) as follows: (0-1= None, 2-4= Mild, 5-7= Moderate, 8-10= Severe) (Figure 1)
baseline, 7, 14, and 21 days
Change in implant stability
The base line primary Implant Stability Quotient (ISQ) will be measured at the time of implant placement, while the secondary stability quotient will be measured after 6months during the prosthetic phase preparation.
baseline and 6 months
Secondary Outcomes (3)
Change in post operative healing
baseline, 7, 14, and 21 days
change in crestal alveolar process width
baseline and 6 months
change in labial bone thickness
baseline and 6 months
Study Arms (1)
Socket shield and immediate implant
EXPERIMENTALInterventions
Tooth Sectioning: The tooth will be sectioned mesiodistally using a fissure bur, preserving the buccal segment. Palatal fragment extraction: carefully after sectioning the tooth , the palatal fragment is luxated and extracted with the most important factor is taking care of the buccal part not to become loose , the extraction is done using a periotome to be minimally invasive and to preserve the bone from major damage. Shield Preparation: The buccal fragment is reduced to bone level using a round bur, a beveled edge is created using a diamond football bur, and the shield is thinned to maintain structural integrity. Implant Site Preparation: Sequential osteotomy performed under copious irrigation, ensuring primary stability. Implant Placement: A Megagen implant is inserted
Eligibility Criteria
You may qualify if:
- Patients with a non-restorable maxillary tooth in the aesthetic zone indicated for extraction and subsequent immediate implant placement.
- Patients with extraction socket Type I.
- A good standard of oral hygiene.
You may not qualify if:
- Patients with extraction socket Type II or III, with defect in the buccal plate.
- Absence of at least 2 mm bone apical to the extraction socket, necessary to obtain adequate primary stability for the implant assessed by pre-operative radiographic evaluation.
- The presence of any local factor that may interfere with extraction as tooth ankylosis.
- Patients with deciduous teeth.
- Patients with bruxism
- Heavy smokers.
- Systemic conditions that are considered as a contraindication for placement of implant or those that may interfere with wound healing and immunocompromised conditions and uncontrolled autoimmune diseases.
- History of oral or intravenous bisphosphonate therapy or any treatments with other medications that may interfere with bone metabolism within the past 12 months.
- Patients receiving radiotherapy or chemotheraphy.
- Patient with active infection or chronic infection with severe bone loss.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beirut Arab University
Beirut, 11-5020, Lebanon
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer of Dental Public Health and biostatistical consultanat
Study Record Dates
First Submitted
July 15, 2025
First Posted
July 24, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
July 24, 2025
Record last verified: 2025-07